Dbv Technologies S A Asset Turnover Ratio (DBVT), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Dbv Technologies S a   (NASDAQ: DBVT)
 

Dbv Technologies S A Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Dbv Technologies S A 's asset turnover ratio, the ratio that measures the ability of Dbv Technologies S A 's assets to generate revenue, sequentially decreased to 0.02 in the second quarter (Jun 30 2026), but it does not raise any concerns as Dbv Technologies S A continue to execute well, and the asset turnover ratio remains above the average.

Within sector 62 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 2956 to 3595.

Asset Turnover Ratio Definition



DBVT Asset Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Asset Change 32.22 % 462.11 % -39.03 % 97.97 % 175.13 %
Y / Y Revenue Change -52.22 % 12.5 % 26.03 % 158.77 % 26.18 %
Asset Turnover Ratio (TTM) 0.02 0.03 0.04 0.03 0.02
DBVT's Total Ranking # 3595 # 2956 # 3093 # 3198 # 2935
Seq. Asset Change -27.26 % 31.3 % 80.23 % -23.19 % 209.26 %
Seq. Revenue Change -22.22 % 39.75 % -76.78 % 89.35 % 83.13 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 63
Healthcare Sector # 523
Overall Market # 3595

Asset Turnover Ratio Statistics
High Average Low
0.09 -0.31 -5.79
(Sep 30 2024)   (Dec 31 2022)







Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Nurix Therapeutics Inc   0.06 $ 36.766  Millions$ 595.569  Millions
Ispecimen inc   0.06 $ 0.466  Millions$ 8.133  Millions
Prophase Labs Inc   0.05 $ 3.150  Millions$ 60.428  Millions
Insight Molecular Diagnostics Inc   0.05 $ 1.670  Millions$ 34.891  Millions
Agape Atp Corporation  0.05 $ 1.152  Millions$ 24.729  Millions
Vistagen Therapeutics Inc   0.04 $ 2.501  Millions$ 62.393  Millions
Northwest Biotherapeutics Inc  0.03 $ 2.173  Millions$ 66.973  Millions
Dbv Technologies S a   0.02 $ 5.018  Millions$ 223.351  Millions
Vivosim Labs Inc   0.01 $ 0.112  Millions$ 8.892  Millions
Envoy Medical Inc   0.01 $ 0.207  Millions$ 17.628  Millions
Bellevue Life Sciences Acquisition Corp  0.01 $ 1.809  Millions$ 171.835  Millions
Sharps Technology Inc   0.01 $ 2.468  Millions$ 263.597  Millions
Clene Inc   0.01 $ 0.197  Millions$ 21.287  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.